Stayble Therapeutics AB (OSTO:STABL) PB Ratio : 0.33 (As of May. 14, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Stayble Therapeutics AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-14), Stayble Therapeutics AB's share price is kr0.239. Stayble Therapeutics AB's Book Value per Share for the quarter that ended in Sep. 2023 was kr0.72. Hence, Stayble Therapeutics AB's PB Ratio of today is 0.33.

The historical rank and industry rank for Stayble Therapeutics AB's PB Ratio or its related term are showing as below:

OSTO:STABL' s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 7.3
Current: 0.33

During the past 7 years, Stayble Therapeutics AB's highest PB Ratio was 7.30. The lowest was 0.00. And the median was 0.00.

OSTO:STABL's PB Ratio is ranked better than
95.96% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs OSTO:STABL: 0.33

During the past 12 months, Stayble Therapeutics AB's average Book Value Per Share Growth Rate was -48.40% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Stayble Therapeutics AB was 51.90% per year. The lowest was 23.50% per year. And the median was 37.70% per year.

Back to Basics: PB Ratio

Stayble Therapeutics AB PB Ratio Historical Data

The historical data trend for Stayble Therapeutics AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stayble Therapeutics AB PB Ratio Chart

Stayble Therapeutics AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

4.39

2.20

3.62

Stayble Therapeutics AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
PB Ratio	Get a 7-Day Free Trial															3.00	3.62	2.25	1.72	6.80

Competitive Comparison of Stayble Therapeutics AB's PB Ratio

For the Biotechnology subindustry, Stayble Therapeutics AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stayble Therapeutics AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stayble Therapeutics AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Stayble Therapeutics AB's PB Ratio falls into.

Stayble Therapeutics AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Stayble Therapeutics AB's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Sep. 2023)
	=	0.239	/	0.719
	=	0.33

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Stayble Therapeutics AB (OSTO:STABL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Stayble Therapeutics AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Stayble Therapeutics AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Stayble Therapeutics AB (OSTO:STABL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stayble Therapeutics AB (OSTO:STABL) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

4K4:Germany

Address

Medicinaregatan 8a, Gothenburg, SWE, SE-413 90

Website

http://www.staybletherapeutics.com

Stayble Therapeutics AB is a clinical-stage pharmaceutical company developing STA363, an intradiscally injected formulation against chronic discogenic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and analgesics. The injection is given once and the effect is expected to remain throughout the patient's life and requires minimal rehabilitation. The company's injection treatment, STA363, is expected to correct the underlying cause of disc-related low back pain by affecting the two main causative factors namely instability of the disc and prevention of leakage of inflammatory mediators from the disc center.

Stayble Therapeutics AB (OSTO:STABL) Headlines

No Headlines